Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.

Date Posted	Organization	Title	Website	Type	LOI and/or Application Due Date	Comments / Documents
11/08/19	NIH	Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)	Link	NIH	Standard due dates apply
11/08/19	NIH	Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)	Link	NIH	Standard due dates apply
10/30/19	NIH	Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)	Link	NIH	Standard due dates apply
10/30/19	NIH	Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)	Link	NIH	Standard due dates apply
10/30/19	Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)	Independent Medical Education Grants	Link	Foundation	Grant applications must be submitted no less than 60 days prior to the program …
10/16/19	NIH	Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required)	Link	NIH	Standard due dates apply	LOI required and due 30 days prior to the application due date.
10/09/19	NIH	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)	Link	NIH	Standard due dates apply
10/09/19	Fanconi Anemia Research Fund (FARF)	Research Grant Awards (RGA)	Link	Foundation	FARF has a rolling submission for letters of intent (LOI) for the RGA program
09/19/19	NSF	Biophotonics	Link	NSF		Full proposals are accepted anytime throughout the year.
09/19/19	NIH	Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed)	Link	NIH		LOI required 30 days prior to the application due date(s) which are: 10/24/19, 6/24/20, 10/22/20, and 6/23/21
09/19/19	NIH	Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed)	Link	NIH		LOI due 30 days prior to the application due date(s) which are 10/24/19, 6/24/20, 10/22/20, and 6/23/21
09/19/19	NIH	Revision Applications for Mechanisms of Cancer Drug Resistance (P50 Clinical Trial Not Allowed)	Link	NIH		LOI required 30 days prior to the application due date(s) which are: 10/24/19, 6/24/20, 10/22/20, and 6/23/21
09/19/19	NIH	Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)	Link	NIH		LOI due 30 days prior to the application due date(s) which are 10/24/19, 6/24/20, 10/22/20, and 6/23/21
09/19/19	NIH	Revision Applications for Mechanisms of Cancer Drug Resistance (U54 Clinical Trial Not Allowed)	Link	NIH		LOI required 30 days prior to the application due date(s) which are: 10/24/19, 6/24/20, 10/22/20, and 6/23/21
09/19/19	American Association for Cancer Research	AACR Basic Cancer Research Fellowships	Link	Foundation
08/21/19	Bayer US	Medical Educational Grants - various grants in Oncology/Hematology	Link	Training	Required Documentation need to be submitted at least 45 days prior to the event…
08/21/19	NIH	Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)	Link	NIH	Standard due dates apply
08/21/19	NIH	Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)	Link	NIH	Standard due dates apply
08/08/19	NIH	POSTBACCALAUREATE INTRAMURAL RESEARCH TRAINING AWARD (POSTBAC IRTA/CRTA)	Link	Training		Interested individuals are encouraged to apply three to six months before they wish to begin their training at the NIH. The program has no fixed start date.
08/08/19	NIH	Assay development and screening for discovery of chemical probes or therapeutic agents (R01)	Link	NIH	Standard due dates apply	LOI required and due 30 days prior to the application due date
08/08/19	NIH	Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)	Link	NIH	Standard due dates apply
08/08/19	NIH	Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)	Link	NIH	Standard due dates apply
08/08/19	NIH	Integration of Individual Residential Histories into Cancer Research (R21)	Link	NIH	Standard due dates apply
08/08/19	NIH	Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)	Link	NIH	Standard due dates apply	LOI required and due 30 days prior to the application due date
08/08/19	NIH	The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)	Link	NIH	Standard due dates apply
08/08/19	NIH	Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)	Link	NIH		LOI required and due 30 days prior to the application due date/s which are: 11/19/19, 6/15/20, 11/17/20, 6/14/21
08/08/19	NIH	Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)	Link	NIH	Standard due dates apply
08/08/19	NIH	Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)	Link	NIH	Standard due dates apply	LOI required and due 30 days prior to the application due date
08/08/19	NIH	Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)	Link	NIH	Standard due dates apply	LOI required and due 30 days prior to the application due date
08/08/19	NIH	Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)	Link		Standard due dates apply